Cardiac Resynchronization Therapy for the Treatment of Heart Failure in Patients with Intraventricular Conduction Delay and Malignant Ventricular Tachyarrhythmias

Journal of the American College of Cardiology

Volumn 42, Issue 8, 2003, Pages 1454-1459

  Higgins, Steven L ^a,j   Hummel, John D ^b   Niazi, Imran K ^c   Giudici, Michael C ^d   Worley, Seth J ^e   Saxon, Leslie A ^f   Boehmer, John P ^g   Higginbotham, Michael B ^h   De Marco, Teresa ^f   Foster, Elyse ^f   Yong, Patrick G ⁱ  

^a SCRIPPS MEMORIAL HOSPITAL   (United States)

^b RIVERSIDE METHODIST HOSPITAL   (United States)

^c St Luke's Presbyterian Hospital   (United States)

^d Genesis Medical Center Davenport   (United States)

^e LANCASTER GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ BOSTON SCIENTIFIC CORPORATION   (United States)

^j Regional Cardiac Arrhythmia Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; DISEASE COURSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE CONDUCTION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUALITY OF LIFE; REDUCTION; STATISTICAL ANALYSIS;

EID: 10744230456     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)01042-8     Document Type: Article

References (20)

1. Adams KF. Heart Failure Society of America guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction - pharmacologic approaches. J Card Fail 1999;5:357-82.
2. Packer M, Cohn JN, editors. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999;83:1A-38A.
3. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block: the effect of interventricular asynchrony. Circulation 1989;79:845-53.
4. Bakker PF, Meijburg H, de Vries JW, et al. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol 2000,4:395-404.
5. Foster AH, Gold MR, McLaughlin JS. Hemodynamic effects of atrio-biventricular pacing in humans. Ann Thorac Surg 1995;59:294-300.
6. Cazeau S, Ritter P, Lazarus A, et al. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996;19: 1748-57.
7. Gras D, Mabo P, Tang T, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol 1998;21:2249-55.
8. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
9. Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000;85:1154-6.
10. Saxon LA, Boehmer JP, Hummel J, et al. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. Am J Cardiol 1999;835:120D-3D.
11. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-73.
12. Jennrich RI, Schlucter MD. Unbalanced repeated measures models with structured covariance matrices. Biometrics 1986;42:805-20.
13. Gregatoros G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31;1175-209.
14. Garg R, Yusuf S, for the collaborative group on ACE inhibitor trials. Overview of randomized trials of angiotensin-converting enzyme inhibitor on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6.
15. Packer M, Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. Circulation 1996;94:2793-9.
16. The RESOLVD Study Investigators. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation 2000;101:378-84.
17. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
18. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 2003;289:2685-94.
19. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION). J Card Fail 2000;6:276-85.
20. Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (CArdiac REsynchronization in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 2001;3:481-9.